
|Articles|November 22, 2004
Hyaluronidase product hailed as welcome revival of old drug
Nationwide drug shortages, many of which are caused by manufacturing problems, often leave hospital-based healthcare professionals in a bind. A few years ago, when Wyeth-Ayerst announced the imminent unavailability of hyaluronidase (Wydase), it sent shock waves throughout the hospital community.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Approves Afibercept-Boav as Biosimilar to Afibercept for Diabetic Macular Edema
2
FDA Approves Risperidone Injection for Bipolar I Disorder in Adults
3
Vaccine Messaging for Teens Should Tailor to Personal Perspectives
4
American Pharmacists Month: Students Seeking Both Common, Non-Traditional Pharmacy Careers
5